Effects of isolated vitamin B6 supplementation on oxidative stress and heart function parameters in experimental hyperhomocysteinemia by Mendes, Roberta Hack et al.
Original Article
http://seer.ufrgs.br/hcpa ISSN 2357-9730 73
Clin Biomed Res. 2017;37(2):73-80
http://dx.doi.org/10.4322/2357-9730.70767
EffEcts of isolatEd vitamin B6 supplEmEntation on 
oxidativE strEss and hEart function paramEtErs in 
ExpErimEntal hypErhomocystEinEmia
Roberta Hack Mendes1,2, Georgia Orsi Candido3, Cristiano Mostarda4, 
Raquel Sirvente3, Vânia D’Almeida5, Maria Flávia Ribeiro6, 
Alex Sander da Rosa Araújo1, Vera Maria Cury Salemi7, 
Katya Rigatto1,8,9, Maria Cláudia Costa Irigoyen1,3, Adriane Belló-Klein1
1 Laboratory of Cardiovascular Physiology 
and Reactive Oxygen Species, Institute 
of Basic Health Sciences, Universidade 
Federal do Rio Grande do Sul (UFRGS). 
Porto Alegre, RS, Brazil.
2 Health Sciences Department, 
Universidade Regional Integrada do Alto 
Uruguai e das Missões (URI). Frederico 
Westphalen, RS, Brazil.
3 Instituto do Coração (InCor), Medical 
School, Universidade de São Paulo 
(USP). São Paulo, SP, Brazil.
4 Universidade Federal do Maranhão 
(UFMA). São Luís, MA, Brazil.
5 Department of Psychobiology, 
Universidade Federal de São Paulo 
(Unifesp). São Paulo, SP, Brazil.
6 Laboratory of Neuro-Humoral Interaction, 
Institute of Basic Health Sciences, 
Universidade Federal do Rio Grande do 
Sul (UFRGS). Porto Alegre, RS, Brazil.
7 Heart Failure Unit, Instituto do Coração 
(InCor), Medical School, Universidade de 
São Paulo (USP). São Paulo, SP, Brazil.
8 Graduation Program in Health Sciences, 
Universidade Federal de Ciências da 
Saúde de Porto Alegre (UFCSPA). Porto 
Alegre, RS, Brazil.
9 Department of Basic Sciences, Division 
of Physiology, Universidade Federal 
de Ciências da Saúde de Porto Alegre 
(UFCSPA). Porto Alegre, RS, Brazil.
 Corresponding author: 
Adriane Belló-Klein 
belklein@ufrgs.br 
Laboratório de Fisiologia Cardiovascular, 
Departamento de Fisiologia, 
Universidade Federal do Rio Grande do 
Sul (UFRGS) 
R. Sarmento Leite, 500. 
90050-170, Porto Alegre, RS, Brazil.
ABSTRACT
Introduction: The purpose of this study was to investigate the effects of isolated 
vitamin B6 (VB6) supplementation on experimental hyperhomocysteinemia (Hhe) 
induced by homocysteine thiolactone (HcyT).
Methods: Fifteen male Wistar rats were divided into three groups according to their 
treatment. Animals received water and food ad libitum and an intragastric probe 
was used to administer water for 60 days (groups: CB6, HcyT, and HB6). On the 
30th day of treatment, two groups were supplemented with VB6 in the drinking water 
(groups: CB6 and HB6). After 60 days of treatment, homocysteine (Hcy), cysteine, and 
hydrogen peroxide concentration, nuclear factor (erythroid-derived 2)-like 2 (NRF2) 
and glutathione S-transferase (GST) immunocontent, and superoxide dismutase 
(SOD), catalase (CAT), and GST activities were measured.
Results: The HcyT group showed an increase in Hcy concentration (62%) in relation 
to the CB6 group. Additionally, GST immunocontent was enhanced (51%) in the HB6 
group compared to the HcyT group. Also, SOD activity was lower (17%) in the HB6 
group compared to the CB6 group, and CAT activity was higher in the HcyT group 
(53%) compared to the CB6 group. Ejection fraction (EF) was improved in the HB6 
group compared to the HcyT group. E/A ratio was enhanced in the HB6 group compared 
to the CB6 group. Correlations were found between CAT activity with myocardial 
performance index (MPI) (r = 0.71; P = 0.06) and E/A ratio (r = 0.6; P = 0.01), and 
between EF and GST activity (r = 0.62; P = 0.02).
Conclusions: These findings indicate that isolated VB6 supplementation may lead 
to the reduction of Hcy concentration and promotes additional benefits to oxidative 
stress and heart function parameters.
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Homocysteine (Hcy) is recognized as an independent risk factor for 
atherosclerosis, which is a leading cause of vascular disease worldwide. 
It may participate in the development of cardiovascular diseases through 
its effects on smooth muscle and vascular endothelium cells1. In addition, 
ischemic heart disease remains a leading cause of premature adult mortality2.
Hcy is a non-protein-forming, sulfur-containing amino acid which is 
metabolized through two pathways: transsulfuration to cysteine (Cys) and 
remethylation to Met3. Hyperhomocysteinemia (Hhe) can be defined as 
Hcy plasma concentration > 12 µmol/L, which is considered a risk factor for 
cardiovascular disease4,5. Vitamin B6 (VB6) participates in the transsulfuration 
of Hcy as an enzymatic cofactor of CβS (cystationine β synthase) with cysteine 
as a final product6.
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Apart of its role in Hcy metabolism, VB6 consumption 
decreases the risk for neuropsychiatric disorders, 
including seizures, migraine, chronic pain, and 
depression, and cardiovascular diseases, such as 
atherosclerosis and endothelial cell proliferation7,8.
Nutritional factors play a fundamental role on Hcy 
metabolism. VB6 is a water-soluble vitamin that can 
be found in different types of food, including fish, 
poultry, whole grains, potatoes, vegetables, and 
nuts. It exists in several forms such as pyridoxal, 
pyridoxine, pyridoxamine, and its active form, pyridoxal 
5’-phosphate (PLP). Low VB6 concentrations could 
reflect, thus, an increased consumption of PLP 
that is associated with an accelerated synthesis of 
inflammatory cytokines9. Additionally, VB6 appears 
to control reactive oxygen species (ROS) production 
similarly to vitamins C and E. It is well established 
in the literature that increased oxidative stress is 
associated with VB6 deficiency
10-12. Moreover, a 
recent case-control study found that a lower status 
of B vitamins (B12, B6, and folate) in the diet and in 
the serum concentration are involved in the etiology 
of hyperhomocysteinemia (Hhe), cardiovascular 
disease, and oxidative stress13.
Thus, the aim of this study was to evaluate oxidative 
stress and heart function parameters after isolated 
VB6 supplementation in an experimental Hhe.
METHODS
Animals and Treatments
The experiment was in accordance with the 
Guidance for the Description of Animal Research in 
Scientific Publications from the National Research 
Council (US) Institute for Laboratory Animal Research14.
Fifteen male Wistar rats (30 days old) from the Animal 
House of the Universidade Federal de São Paulo, 
maintained in standard conditions (12h/12h light/dark 
cycle, room temperature at 21ºC, food and water ad 
libitum), were divided into three groups: 1) CB6: rats 
received water by intragastric probe for 60 days, 
and from the 30th to the 60th day they also received 
supplementation with pyridoxine hydrochloride (60 mg/kg) 
diluted in the water; 2) HcyT: rats received water 
containing homocysteine thiolactone (L-homocysteine 
thiolactone hydrochloride, Sigma; 100 mg/kg) by 
intragastric probe for 60 days; 3) HB6: rats received 
water containing homocysteine thiolactone (100 mg/kg) 
by intragastric probe for 60 days, and from the 30th to 
the 60th day they also received supplementation with 
pyridoxine hydrochloride (60 mg/kg). Animals were 
weighed at the beginning and at the end of the 
experiment. After 60 days, animals were euthanized 
by decapitation, and blood and hearts were collected. 
Blood was immediately processed, and hearts were 
stored at -80ºC for posterior biochemical analysis.
Homocysteine and Cysteine Assay
Blood was centrifuged for 5 minutes at 3,000 g 
in tubes containing anticoagulant, and plasma was 
collected. Total homocysteine and cysteine levels were 
determined by high performance liquid chromatography 
(HPLC) with fluorescence detection, as performed 
by Oliveira et al.15.
ROS Evaluation
Hydrogen peroxide was measured through the 
horseradish peroxidase (HRPO)-mediated oxidation 
of phenol red. Slices of left ventricular (LV) tissue 
were incubated for 30 minutes at 37°C in 10 mmol/L 
phosphate buffer (140 mmol/L NaCl and 5 mmol/L 
dextrose). Supernatants were transferred to tubes 
with 0.28 mmol/L phenol red and 8.5 U/mL HRPO. 
After 25 minutes of incubation, 1 mol/L NaOH was 
added and the absorbance of the solution was 
measured at 610 nm. Results were expressed in 
nmoles H2O2 per g of tissue
16.
Western Blot Analysis
Thirty micrograms of protein were submitted to 
a 12% one-dimensional sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE)17. 
The separated proteins were transferred to nitrocellulose 
membranes using a buffer containing 20 mmol/L Tris, 
150 mmol/L glycine, 20% (v/v) methanol, 0.1% (w/v) 
SDS, pH 8.2, in a cooled Bio-Rad TransBlot unit. 
Non-specific protein-binding sites were blocked with 
non-fat milk in Tris-buffer for 1 hour18. The membranes 
were processed for immunodetection using rabbit 
anti-NFR2 (52kDa) and mouse anti-GST (26kDa) 
(both from Santa Cruz Biotechnology, Santa Cruz, 
CA, USA) incubated at 4°C. Bound primary antibodies 
were detected using rabbit anti-goat and rabbit 
anti-mouse, and membranes were developed using 
chemiluminescence. Autoradiographic images were 
scanned and analyzed using an image software (Image 
master VDS CI, Amersham Biosciences Europe, IT). 
Results of each membrane were normalized through 
Ponceau S staining19.
Determination of Protein Concentration
Protein was measured by the method of Lowry et al. 
(1951) using a standard solution of bovine serum 
albumin20.
Preparation of Erythrocytes
Heparinized venous blood samples were 
washed in a solution of 9 g/L sodium chloride and 
centrifuged three times at 3000 g for 10 minutes at 
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room temperature. White cells were discarded by 
aspiration. Erythrocytes were diluted 1/10 in 1 mM 
acetic acid and 4 mM magnesium sulfate, placed 
on an ice bath for 10 minutes, and centrifuged at 
4200 g for 20 minutes at 0ºC. Supernatant was used 
for enzyme assays21.
Determination of Antioxidant Enzyme Activities 
in Erythrocytes
The quantification of superoxide dismutase (SOD) 
activity, expressed as units per milligram of protein, 
was based on the inhibition of superoxide radical 
reaction with pyrogallol22. Catalase (CAT) activity 
was determined by following a decrease in hydrogen 
peroxide (H2O2) absorbance at 240 nm. It was 
expressed as nanomol of H2O2 reduced per minute 
per milligram of protein23. Glutathione-S-transferase 
(GST) activity, expressed as nanomol per milligram 
of protein, was measured by the rate of formation of 
dinitrophenyl-S-glutathione at 340 nm24.
Echocardiographic Evaluation
A transthoracic echocardiography was performed 
in all experimental animals at the end of treatment 
using a SEQUOIA 512 equipment (ACUSON, Mountain 
View, CA, USA), with a 13-MHz linear transducer. 
Rats were anesthetized with a combination of ketamine 
(80 mg/kg, ip) and xylazine (10 mg/kg, ip). Images were 
obtained with the transducer placed on the animal’s 
shaved chest in the supine position and were optimized 
using a transmission gel. All measurements were based 
on an average of three consecutive cardiac cycles. 
Echocardiographic indices were obtained according 
to the recommendations of the American Society of 
Echocardiography. Ejection fraction (EF) was calculated 
from M-mode recordings to assess the following 
parameters: (1) morphometric: LV mass, LV diastolic 
diameter corrected by weight (LVDD/kg), and relative 
wall thickness (RWT); (2) systolic function: EF; 
(3) diastolic function: LV isovolumic relaxation time 
(IVRT) and ratio of peak velocity of early (E) and 
late (A) diastolic filling (E/A ratio); and (4) overall 
function: myocardial performance index (MPI), as 
previously described25.
Statistical Analysis
Data are expressed as mean ± standard deviation 
(SD). Data were tested for normal distribution using 
the Shapiro-Wilk test, and the one-way analysis of 
variance followed by the Tukey test was used to compare 
groups. Pearson’s correlation was used to study the 
association between heart function parameters and 
CAT (pmol/mg protein) and GST (nmol/mg protein). 
Significance level was established at P ≤ 0.05. 
Data were analyzed using SPSS, version 19.0.
RESULTS
Total Hcy plasma concentration (μmol/L) was higher 
(98%) in the HcyT group after treatment compared 
to the CB6 group, demonstrating the efficiency of 
our experimental protocol. Cysteine concentration 
and body weight were not affected by the treatment 
with HcyT (table 1).
Regarding antioxidant enzyme activities, there 
was a decrease in SOD activity (U/mg protein) and 
GST activity (nmol/mg protein) in erythrocytes of the 
HB6 group compared to the CB6 group. Conversely, 
the HB6 group showed an increase in GST activity 
compared to the HcyT group. Furthermore, CAT activity 
(pmol/mg protein) was lower in the HcyT group 
compared to the CB6 group (table 2).
There was an increase (62%) in H2O2 concentration 
in the HcyT group compared to the CB6 group. 
Table 1: Metabolic evaluations in studied groups.
CB6 HcyT HB6
Hcy concentration (μmol/L) 8.6 ± 0.9 17.0 ± 1.4* 9.0 ± 1.0**
Cys concentration (μmol/L) 294.2 ± 32.5 327.9 ± 26 331.5 ± 36.1
Initial body weight (g) 249.0 ± 6.5 260.0 ± 18.0 244.5 ± 27.5
Final body weight (g) 444.0 ± 22.6 420.3 ± 35 456.0 ± 12.5
CB6 = control + vitamin B6; HcyT = homocysteine thiolactone; HB6 = homocysteine + vitamin B6. Data are reported as mean ± SD. 
*P < 0.05 vs CB6; **P < 0.05 vs HcyT.
Table 2: Antioxidant enzyme activities in erythrocytes.
Parameter CB6 HcyT HB6
SOD (U/mg protein) 13.88 ± 2.79 8.17 ± 1.14* 11.51 ± 2.14
CAT (pmol/mg protein) 89 ± 17 131 ± 19* 72 ± 15**
GST (nmol/mg protein) 98 ± 19 24 ± 4 61 ± 17*,**
CB6 = control + vitamin B6; HcyT = homocysteine thiolactone; HB6 = homocysteine + vitamin B6. Data are reported as mean ± SD. *P < 0.05 
vs CB6; **P < 0.05 vs HcyT. SOD = superoxide dismutase; CAT = catalase; GST = glutathione S-transferase.
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However, H2O2 concentration in the HB6 group 
was similar to that in the CB6 group (figure 1). 
The HcyT group showed a significant decrease (46%) 
in NRF2 immunocontent in relation to the CB6 group 
(figure 2). Furthermore, the HB6 group showed an 
increase in GST immunocontent (51%) compared 
to the HcyT group (figure 3).
In relation to heart function, the HB6 group showed 
increased LVDD/Kg in relation to the CB6 and HcyT groups. 
Moreover, RWT is decreased in HB6 group in relation 
to the HcyT group. Considering LV systolic function 
variables, EF was significantly decreased (9.5%) in 
the HB6 group compared to the CB6 group, as well as 
in the HcyT group compared to the CB6 (20%) and 
HB6 (10%) groups. Global LV function assessment 
with MPI was increased in the HcyT group in relation 
to the CB6 (29.5%) and HB6 (30%) groups. E/A ratio 
was enhanced in the HcyT group compared to the 
CB6 group. Conversely, the HB6 group showed 
decreased IVRT in relation to the CB6 and HcyT 
groups (table 3).
Correlations were found between increased 
CAT activity and increased MPI (r = 0.71; P = 0.006), 
as well as in increased E/A ratio (r = 0.6; P = 0.01).
Systolic cardiac function, measured by echocardiogram 
and represented by EF, was correlated with increased 
concentration of GST activity (r = 0.62; P = 0.02).
DISCUSSION
The main findings of the present study were 
that isolated VB6 supplementation reduced plasma 
concentration of Hcy, restored antioxidant enzyme 
activities in erythrocytes, reduced H2O2 concentration, 
Figure 1: The effect of VB6 supplementation on H2O2 levels 
in hyperhomocysteinemia (Hhe) model. H2O2 concentration 
was measured in cardiac tissue by spectrophotometry 
at the end of experimental protocol in CB6 (0.36±0.06), 
HT (0.93±0.14) ans HTB6 (0.31±0.06) groups. Values 
are presented as mean ± SD from 5 animals per group. 
† p<0.05 vs. CB6 and ‡ p<0.05 vs. HT (p<0.05).
Figure 2: Nrf2 immunocontent in cardiac tissue: Protein 
expression of Nrf2 was measured by western blot technique in 
cardiac tissue of CB6 (n=5), HT (n=5) and HTB6 (n=5) animals. 
Image represents a blot containing Nrf2 immunocontent of 
three animals per group. Data are represented by mean ± 
SD of mega pixels of each experimental. † p<0.05 vs. CB6 
and ‡ p<0.05 vs. HT (p<0.05).
Figure 3: Glutathione S- Transferase immunocontent in 
cardiac tissue: Protein expression of GST was measured 
by western blot technique in cardiac tissue of CB6 (n=5), 
HT (n=5) and HTB6 (n=5) animals. Image represents a 
blot containing GST immunocontent of three animals per 
group. Data are represented by mean ± SD of mega pixels 
of each experimental. † p<0.05 vs. CB6 and ‡ p<0.05 vs. 
HT (p<0.05).
and improved heart function parameters in this 
model of Hhe.
We observed that Hcy plasma concentration 
decreased significantly after the CB6 and HB6 groups 
received isolated VB6 supplementation for 30 days 
compared to the HcyT group. Previous studies have 
demonstrated that VB6 deficiency induced a significant 
Hhe. We also observed that folate supplementation 
improves Hhe induced by VB6 deficiency
26. Conversely, 
epidemiological studies have demonstrated that 
VB6 has an important role in the prevention of 
atherosclerosis regardless of the reduction of plasma 
homocysteine concentration, but the exact mechanism 
responsible for this remains unclear27-29. One plausible 
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mechanism is the endogenous production of H2S by 
the transsulfuration pathway that mediates cysteine 
production from catabolism of Hcy. H2S is a gaseous 
signaling molecule that modulates physiologic 
actions, such as relaxation of smooth muscle, and 
attenuates myocardial ischemia-reperfusion injury by 
protecting mitochondrial function30. These findings, 
together with ours, suggest that VB6 is important for 
cerebrovascular protection and that the mechanism 
involved in this process could be related to the 
transsulfuration pathway.
Furthermore, VB6 supplementation did not 
change the body weight of the animals. This result 
demonstrates that VB6 supplementation did not 
influence the metabolic control of animals (data not 
shown).
The groups that received VB6 supplementation 
(CB6 and HB6) showed a significant reduction in H2O2, 
a signaling molecule, indicating that VB6 might act as 
a ROS quencher. A recent study reported that a VB6 
deficient diet seemed to mediate the oxidative stress 
in connection with the redistribution of glutathione 
from liver to plasma, but did not further affect 
glutathione-related enzyme activities in mice with 
homocysteine-induced oxidative stress31. Another 
previous study with Japanese women demonstrated 
that VB6 plays a role against oxidative DNA damage, 
but not folate and homocysteine32. One of the 
possible reasons for our results is the ability of 
VB6 to inhibit xanthine oxidase activity, which is an 
enzyme responsible for the formation of uric acid 
and hydrogen peroxide33.
The detoxification of xenobiotics seems to be 
related with the GST enzyme and is regulated by 
NRF2. In the present study, GST immunocontent 
increased significantly in the groups that received 
VB6 supplementation, and the HB6 group showed the 
highest level of GST immunocontent. One plausible 
explanation for this result is that VB6 supplementation 
preserved GST immunocontent. Conversely, the 
depletion of GST occurs during Hhe due to the role 
of this enzyme in cysteine metabolism.
In the present study, the HB6 group showed an 
increase in NRF2 immunocontent compared to the 
HcyT group. The method used for this evaluation is 
suitable for the cytoplasmic portion; however, it is 
known that when activated NRF2 is in the nuclear 
portion. It is a possible explanation for an increased 
NRF2 immunocontent in the cytoplasmic portion. 
Other study using hepatoma cell line demonstrated 
that Hcy activates NRF2 transcription (from the 
cytoplasmic portion to the nuclear portion) inducing 
antioxidant-related genes34.
Regarding antioxidant enzyme activities in 
erythrocytes, we observed that SOD and GST 
activities decreased in the HcyT group compared 
to the CB6 group. We also found that CAT activity 
increased in the HcyT group when compared to 
the CB6 and HB6 groups. Additionally, GST activity 
increased in the HB6 group compared to the HcyT 
group. The relevance of measuring blood oxidative 
stress parameters by standardized methods may be 
useful to define the role of oxidative stress in different 
diseases and also for clinical diagnosis21, 35.
The exact mechanism by which VB6 acts as 
an antioxidant is not clear yet. One possible direct 
mechanism might be that VB6 has both hydroxyl 
and amine groups as substitutes on a pyridine ring, 
which may react with peroxy radicals and thereby 
scavenge radicals and lipid peroxides. Moreover, an 
indirect mechanism by which VB6 compounds play 
the role of antioxidant may be through serving as a 
coenzyme in the glutathione enzyme system36.
In the present study, LV mass and LVDD/kg was 
increased in the HB6 group when compared to the 
other groups. A previous study with chronic uremic 
patients demonstrated a direct correlation between 
total plasma homocysteine level and LV mass index37. 
Table 3: Parameters on echocardiography of experimental groups.
Parameter CB6 HcyT HB6
Heart rate (bpm) 234 ± 25 258 ± 17 243 ± 12
LVM (g/kg) 2.60 ± 0.13 2.70 ± 0.45 2.90 ± 0.33
RWT (cm) 0.40 ± 0.04 0.44 ± 0.02 0.36 ± 0.02**
LVDD (cm/kg) 1.53 ± 0.18 1.56 ± 0.13 1.70 ± 0.13*,**
E/A ratio 1.75 ± 0.25 2.16 ± 0.22* 1.99 ± 0.10
EF (%) 84.00 ± 0.07 69.00 ± 0.04* 76.00 ± 0.04*,**
MPI 0.31 ± 0.16 0.44 ± 0.11* 0.30 ± 0.11**
IVRT (ms) 25.00 ± 1.46 25.00 ± 1.40 22.00 ± 1.75*,**
CB6= control + vitamin B6; HcyT = homocysteine; HB6 = homocysteine + vitamin B6. Data are reported as mean ± SD. *P < 0.05 vs CB6; 
**P < 0.05 vs HcyT. Heart rate (bpm) = beat per minute; LVM (g/kg) = left ventricular mass on echocardiography (adjusted per weight); RWT 
(cm) = relative wall thickness; LVDD (cm/kg) = left ventricular diastolic diameter (adjusted per body weight); E/A ratio: ratio of peak velocity 
of early (E) and late (A) diastolic filling; EF = ejection fraction; MPI: myocardial perfusion imaging; IVRT (ms) = isovolumic relaxation time.
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One possible reason for this result is the duration of 
isolated VB6, which was not long enough to protect 
cardiac morphological against the Hhe effect.
Conversely, concerning systolic function, 
EF was decreased in the HB6 group compared to 
the CB6 group. However, the HB6 group showed a 
significant improvement in relation to the HcyT group. 
A previous study investigated the effect of micronutrient 
supplementation (calcium, magnesium, zinc, copper, 
selenium, vitamin A, thiamine, folate, vitamin B12, 
C, E, D, and coenzyme Q10, riboflavin, VB6) for 
9 months on elderly patients with chronic cardiac 
failure and observed a significant improvement in 
EF38. This result, in agreement with ours, reinforces 
the hypothesis of association between redox balance 
and cardiac function.
In relation to LV diastolic function, IVRT was 
reduced in the HB6 group in relation to the CB6 and 
HcyT groups. This finding might be suggestive of 
diastolic dysfunction, probably by the HcyT effect of 
increased endothelial-myocyte uncoupling, resulting 
in hypertension39. E/A ratio was increased in the Hcy 
group compared to the CB6 group. In agreement with 
our findings, other study investigated the effects of 
plasma Hcy on LV diastolic function of Chinese patients 
with essential hypertension and found a lower E/A ratio 
and significant correlations between LV diastolic 
function indices and Hcy levels40. Our results suggest 
that the period used for VB6 supplementation was 
not enough to protect diastolic function from Hhe.
LV global function by pulsed-wave MPI was 
increased in the HcyT group in relation to the CB6 group. 
However, the HB6 group showed a decrease in MPI, 
as expected. MPI has prognostic values in different 
diseases, including chronic obstructive pulmonary 
disease and pulmonary artery hypertension41,42. 
We found positive correlations between increased 
CAT activity and increased MPI, which could be 
explained by the high production of H2O2 in the body 
that will need to be converted by CAT. H2O2 toxicity will 
probably act negatively on heart function. Considering 
the increase in E/A ratio, we suggest that exists an 
association between increased H2O2 production, 
which is converted by CAT, and the myocardial 
stiffness caused by increased E/A ratio. EF was also 
correlated with an increase in GST activity, indicating 
a protective role of this enzyme in systolic heart 
function. This correlation reinforces the association 
of oxidative and heart function parameters in this 
experimental model.
Collectively, these findings demonstrated that 
isolated supplementation of VB6 seems to modulate 
antioxidant enzyme activities and some heart function 
parameters.
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